Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 67

1.

A global scientific strategy to cure hepatitis B.

Revill PA, Chisari FV, Block JM, Dandri M, Gehring AJ, Guo H, Hu J, Kramvis A, Lampertico P, Janssen HLA, Levrero M, Li W, Liang TJ, Lim SG, Lu F, Penicaud MC, Tavis JE, Thimme R; Members of the ICE-HBV Working Groups; ICE-HBV Stakeholders Group Chairs; ICE-HBV Senior Advisors, Zoulim F.

Lancet Gastroenterol Hepatol. 2019 Apr 10. pii: S2468-1253(19)30119-0. doi: 10.1016/S2468-1253(19)30119-0. [Epub ahead of print]

PMID:
30981686
2.

Cellular Gene Expression during Hepatitis C Virus Replication as Revealed by Ribosome Profiling.

Gerresheim GK, Bathke J, Michel AM, Andreev DE, Shalamova LA, Rossbach O, Hu P, Glebe D, Fricke M, Marz M, Goesmann A, Kiniry SJ, Baranov PV, Shatsky IN, Niepmann M.

Int J Mol Sci. 2019 Mar 15;20(6). pii: E1321. doi: 10.3390/ijms20061321.

3.

Host Biology and Anthropogenic Factors Affect Hepadnavirus Infection in a Neotropical Bat.

Hiller T, Rasche A, Brändel SD, König A, Jeworowski L, Teague O'Mara M, Cottontail V, Page RA, Glebe D, Drexler JF, Tschapka M.

Ecohealth. 2019 Mar;16(1):82-94. doi: 10.1007/s10393-018-1387-5. Epub 2018 Dec 18.

PMID:
30564998
4.

Author Correction: Ancient hepatitis B viruses from the Bronze Age to the Medieval period.

Muhlemann B, Jones TC, de Barros Damgaard P, Allentoft ME, Shevnina I, Logvin A, Usmanova E, Panyushkina IP, Boldgiv B, Bazartseren T, Tashbaeva K, Merz V, Lau N, Smrčka V, Voyakin D, Kitov E, Epimakhov A, Pokutta D, Vicze M, Price TD, Moiseyev V, Hansen AJ, Orlando L, Rasmussen S, Sikora M, Vinner L, Osterhaus ADME, Smith DJ, Glebe D, Fouchier RAM, Drosten C, Sjogren KG, Kristiansen K, Willerslev E.

Nature. 2018 Oct;562(7726):E4. doi: 10.1038/s41586-018-0406-6.

PMID:
30108364
5.

Hepatitis B virus subgenotype F3 reactivation with vaccine escape mutations: A case report and review of the literature.

Schlabe S, van Bremen K, Aldabbagh S, Glebe D, Bremer CM, Marsen T, Mellin W, Cristanziano VD, Eis-Hübinger AM, Spengler U.

World J Hepatol. 2018 Jul 27;10(7):509-516. doi: 10.4254/wjh.v10.i7.509.

6.

Hepatitis B virus upregulates host microRNAs that target apoptosis-regulatory genes in an in vitro cell model.

Nielsen KO, Jacobsen KS, Mirza AH, Winther TN, Størling J, Glebe D, Pociot F, Hogh B.

Exp Cell Res. 2018 Oct 1;371(1):92-103. doi: 10.1016/j.yexcr.2018.07.044. Epub 2018 Jul 27.

7.

Hepatitis B virus suppresses the secretion of insulin-like growth factor binding protein 1 to facilitate anti-apoptotic IGF-1 effects in HepG2 cells.

Nielsen KO, Mirza AH, Kaur S, Jacobsen KS, Winther TN, Glebe D, Pociot F, Hogh B, Størling J.

Exp Cell Res. 2018 Sep 15;370(2):399-408. doi: 10.1016/j.yexcr.2018.07.002. Epub 2018 Jul 4.

8.

Characterisation of the hepatitis B virus cross-species transmission pattern via Na+/taurocholate co-transporting polypeptides from 11 New World and Old World primate species.

Müller SF, König A, Döring B, Glebe D, Geyer J.

PLoS One. 2018 Jun 18;13(6):e0199200. doi: 10.1371/journal.pone.0199200. eCollection 2018.

9.

Tenofovir to Prevent Perinatal Transmission of Hepatitis B.

Gerlich W, Glebe D.

N Engl J Med. 2018 Jun 14;378(24):2349. doi: 10.1056/NEJMc1805396. No abstract available.

PMID:
29900726
10.

Ancient hepatitis B viruses from the Bronze Age to the Medieval period.

Mühlemann B, Jones TC, Damgaard PB, Allentoft ME, Shevnina I, Logvin A, Usmanova E, Panyushkina IP, Boldgiv B, Bazartseren T, Tashbaeva K, Merz V, Lau N, Smrčka V, Voyakin D, Kitov E, Epimakhov A, Pokutta D, Vicze M, Price TD, Moiseyev V, Hansen AJ, Orlando L, Rasmussen S, Sikora M, Vinner L, Osterhaus ADME, Smith DJ, Glebe D, Fouchier RAM, Drosten C, Sjögren KG, Kristiansen K, Willerslev E.

Nature. 2018 May;557(7705):418-423. doi: 10.1038/s41586-018-0097-z. Epub 2018 May 9. Erratum in: Nature. 2018 Oct;562(7726):E4.

PMID:
29743673
11.

A novel hepatitis B virus species discovered in capuchin monkeys sheds new light on the evolution of primate hepadnaviruses.

de Carvalho Dominguez Souza BF, König A, Rasche A, de Oliveira Carneiro I, Stephan N, Corman VM, Roppert PL, Goldmann N, Kepper R, Müller SF, Völker C, de Souza AJS, Gomes-Gouvêa MS, Moreira-Soto A, Stöcker A, Nassal M, Franke CR, Rebello Pinho JR, Soares MDCP, Geyer J, Lemey P, Drosten C, Netto EM, Glebe D, Drexler JF.

J Hepatol. 2018 Jun;68(6):1114-1122. doi: 10.1016/j.jhep.2018.01.029. Epub 2018 Feb 8.

12.

Activity of nucleic acid polymers in rodent models of HBV infection.

Schöneweis K, Motter N, Roppert PL, Lu M, Wang B, Roehl I, Glebe D, Yang D, Morrey JD, Roggendorf M, Vaillant A.

Antiviral Res. 2018 Jan;149:26-33. doi: 10.1016/j.antiviral.2017.10.022. Epub 2017 Nov 8.

13.

Quantification of large and middle proteins of hepatitis B virus surface antigen (HBsAg) as a novel tool for the identification of inactive HBV carriers.

Pfefferkorn M, Böhm S, Schott T, Deichsel D, Bremer CM, Schröder K, Gerlich WH, Glebe D, Berg T, van Bömmel F.

Gut. 2018 Nov;67(11):2045-2053. doi: 10.1136/gutjnl-2017-313811. Epub 2017 Sep 26.

PMID:
28951526
14.

Point-of-care screening for hepatitis B virus infection in pregnant women at an antenatal clinic: A South African experience.

Chotun N, Preiser W, van Rensburg CJ, Fernandez P, Theron GB, Glebe D, Andersson MI.

PLoS One. 2017 Jul 21;12(7):e0181267. doi: 10.1371/journal.pone.0181267. eCollection 2017.

16.

Comparative characterization of hepatitis B virus surface antigen derived from different hepatitis B virus genotypes.

Hassemer M, Finkernagel M, Peiffer KH, Glebe D, Akhras S, Reuter A, Scheiblauer H, Sommer L, Chudy M, Nübling CM, Hildt E.

Virology. 2017 Feb;502:1-12. doi: 10.1016/j.virol.2016.12.003. Epub 2016 Dec 9.

17.

Detection of hepatitis b virus DNA in the blood of a stem cell donor after granulocyte colony-stimulating factor treatment.

Punzel M, Medd P, Hunter H, Cunningham R, Pottinger B, Burde B, Widera M, Quade A, Ehninger G, Kozlova A, Schmidt H, Buhrmann K, Schüttler CG, Glebe D, Billen A, Schmidt AH, Mengling T, Verheyen J.

Hepatology. 2016 Nov;64(5):1803-1805. doi: 10.1002/hep.28667. Epub 2016 Jul 9. No abstract available.

PMID:
27240006
18.

Development of an Allergy Immunotherapy Leads to a New Type of Hepatitis B Vaccine.

Gerlich WH, Glebe D.

EBioMedicine. 2016 Sep;11:5-6. doi: 10.1016/j.ebiom.2016.07.032. Epub 2016 Jul 27. No abstract available.

19.

International collaborative study on the 3rd WHO International Standard for hepatitis B surface antigen.

Wilkinson DE, Seiz PL, Schüttler CG, Gerlich WH, Glebe D, Scheiblauer H, Nick S, Chudy M, Dougall T, Stone L, Heath AB; Collaborative Study Group.

J Clin Virol. 2016 Sep;82:173-180. doi: 10.1016/j.jcv.2016.06.003. Epub 2016 Jun 6.

20.

Characterization of the 3rd International Standard for hepatitis B virus surface antigen (HBsAg).

Seiz PL, Mohr C, Wilkinson DE, Ziebuhr J, Schüttler CG, Gerlich WH, Glebe D.

J Clin Virol. 2016 Sep;82:166-172. doi: 10.1016/j.jcv.2016.05.009. Epub 2016 Jun 3.

PMID:
27345250

Supplemental Content

Loading ...
Support Center